“…Although no other long-term safety data for gabapentin in patients with PHN were found, gabapentin has been administered for Z6 months to patients with epilepsy, fibromyalgia, and pain after spinal cord injury. 10,11,[22][23][24] Dizziness (25%), somnolence (19%), edema (16%), and headache (27%) were common AEs when gabapentin was administered for 6 months to patients with fibromyalgia. 11 In a 2-year interim report on the safety and efficacy of gabapentin in patients with refractory partial seizures, central nervous system AEs reported by >10% of patients included dizziness, somnolence, nystagmus, diplopia, tremor, and ataxia.…”